JENNIFER BERNT: Open Payments
NPI 1336641463 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,402 in 69 payments from 23 companies in 2025. Trend: 2023 $1,860 · 2024 $1,765 · 2025 $2,402
Food & beverage: $2,069Education: $333
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $472 |
| Janssen Biotech, Inc. | 7 | $387 |
| Novartis Pharmaceuticals Corporation | 9 | $189 |
| Incyte Corporation | 4 | $164 |
| Astellas Pharma US Inc | 3 | $156 |
| E.R. Squibb & Sons, L.L.C. | 4 | $135 |
| Celgene Corporation | 7 | $128 |
| ABBVIE INC. | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 1 | $104 |
| Gilead Sciences, Inc. | 1 | $101 |
Products named: RYBREVANT, REBLOZYL, Enhertu, Vyloy, EPKINLY, LIBTAYO, Trodelvy, DARZALEX.
Industry payments across AZ — which companies pay providers there.
